Task C1D1: A Study to Evaluate the Pharmacokinetics and Safety of a Therapeutic for Antibiotic-Resistant Tuberculosis

NIH RePORTER · NIH · N01 · $59,004 · view on reporter.nih.gov ↗

Abstract

The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases and can carry out all aspects of interventional clinical trial implementation.

Key facts

NIH application ID: 11166262
Project number: 75N93022D00018-P00002-759302300001-1
Recipient: ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
Principal Investigator: ROBERT SPITZ
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $59,004
Award type: —
Project period: 2023-07-05 → 2025-07-14